 Kyros Ipaktchi
Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 13 | 2009 | 325 | 1.560 |
Why?
| | Amputation, Traumatic | 6 | 2023 | 20 | 1.370 |
Why?
| | Replantation | 6 | 2023 | 31 | 1.320 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 5 | 2009 | 283 | 1.050 |
Why?
| | Finger Injuries | 2 | 2023 | 23 | 0.980 |
Why?
| | Hand | 3 | 2024 | 156 | 0.900 |
Why?
| | Contraindications, Procedure | 1 | 2023 | 11 | 0.840 |
Why?
| | Orthopedic Procedures | 2 | 2024 | 216 | 0.830 |
Why?
| | Median Nerve | 1 | 2023 | 24 | 0.810 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2023 | 32 | 0.810 |
Why?
| | Operating Rooms | 1 | 2024 | 123 | 0.800 |
Why?
| | Carpal Tunnel Syndrome | 1 | 2023 | 27 | 0.800 |
Why?
| | Iatrogenic Disease | 1 | 2023 | 67 | 0.780 |
Why?
| | Oximetry | 1 | 2023 | 96 | 0.770 |
Why?
| | Radius Fractures | 3 | 2014 | 59 | 0.770 |
Why?
| | Microsurgery | 3 | 2024 | 75 | 0.640 |
Why?
| | Wrist Injuries | 3 | 2014 | 23 | 0.620 |
Why?
| | Blood-Brain Barrier | 2 | 2009 | 138 | 0.560 |
Why?
| | Osteotomy | 2 | 2025 | 119 | 0.550 |
Why?
| | Imidazoles | 3 | 2009 | 238 | 0.550 |
Why?
| | Bone Plates | 2 | 2018 | 77 | 0.480 |
Why?
| | Pyridines | 3 | 2009 | 506 | 0.460 |
Why?
| | Enzyme Inhibitors | 3 | 2007 | 840 | 0.460 |
Why?
| | Amputation Stumps | 1 | 2014 | 7 | 0.450 |
Why?
| | Complement C5a | 3 | 2009 | 71 | 0.430 |
Why?
| | Elbow Joint | 2 | 2014 | 71 | 0.410 |
Why?
| | Elbow | 1 | 2013 | 55 | 0.390 |
Why?
| | Lower Extremity | 2 | 2014 | 427 | 0.380 |
Why?
| | Fractures, Malunited | 1 | 2011 | 9 | 0.370 |
Why?
| | Bone Transplantation | 1 | 2011 | 90 | 0.350 |
Why?
| | Mammaplasty | 2 | 2009 | 105 | 0.330 |
Why?
| | Fractures, Bone | 2 | 2013 | 380 | 0.330 |
Why?
| | Dermatitis | 2 | 2007 | 20 | 0.330 |
Why?
| | Clinical Competence | 2 | 2025 | 1118 | 0.310 |
Why?
| | Pituitary Diseases | 1 | 2009 | 20 | 0.310 |
Why?
| | Brain Edema | 1 | 2009 | 61 | 0.310 |
Why?
| | Wrist | 2 | 2023 | 54 | 0.300 |
Why?
| | Encephalitis | 1 | 2009 | 136 | 0.270 |
Why?
| | Physician's Role | 1 | 2009 | 211 | 0.260 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2006 | 93 | 0.250 |
Why?
| | Forearm | 2 | 2023 | 119 | 0.250 |
Why?
| | Fingers | 2 | 2023 | 88 | 0.240 |
Why?
| | Ulna | 1 | 2025 | 27 | 0.240 |
Why?
| | Sepsis | 2 | 2009 | 617 | 0.230 |
Why?
| | Peer Review | 1 | 2025 | 49 | 0.230 |
Why?
| | Peer Review, Research | 1 | 2025 | 43 | 0.230 |
Why?
| | Myocardial Contraction | 5 | 2009 | 341 | 0.230 |
Why?
| | Xylazine | 1 | 2024 | 14 | 0.220 |
Why?
| | Pseudomonas aeruginosa | 1 | 2007 | 352 | 0.220 |
Why?
| | Humans | 31 | 2025 | 137585 | 0.220 |
Why?
| | Soft Tissue Injuries | 1 | 2024 | 33 | 0.220 |
Why?
| | Fluoroscopy | 1 | 2024 | 154 | 0.220 |
Why?
| | Self Mutilation | 1 | 2023 | 5 | 0.210 |
Why?
| | Necrosis | 1 | 2024 | 246 | 0.210 |
Why?
| | Compression Bandages | 1 | 2023 | 5 | 0.210 |
Why?
| | Receptor, Anaphylatoxin C5a | 3 | 2009 | 30 | 0.200 |
Why?
| | Bandages | 1 | 2023 | 37 | 0.200 |
Why?
| | Rats, Sprague-Dawley | 8 | 2009 | 2486 | 0.200 |
Why?
| | Periodicals as Topic | 1 | 2025 | 211 | 0.200 |
Why?
| | Healthy Volunteers | 1 | 2023 | 199 | 0.190 |
Why?
| | Cytokines | 5 | 2009 | 2085 | 0.190 |
Why?
| | Male | 21 | 2025 | 67762 | 0.190 |
Why?
| | Cadaver | 1 | 2023 | 296 | 0.190 |
Why?
| | Artificial Intelligence | 1 | 2025 | 279 | 0.190 |
Why?
| | Postoperative Care | 1 | 2023 | 261 | 0.180 |
Why?
| | Pneumonia | 1 | 2007 | 639 | 0.180 |
Why?
| | Critical Care | 1 | 2006 | 601 | 0.180 |
Why?
| | Psychotic Disorders | 1 | 2023 | 170 | 0.180 |
Why?
| | Regional Blood Flow | 1 | 2023 | 474 | 0.180 |
Why?
| | Rats | 9 | 2009 | 5647 | 0.170 |
Why?
| | Radiography | 2 | 2013 | 822 | 0.160 |
Why?
| | Debridement | 2 | 2024 | 81 | 0.160 |
Why?
| | Nerve Transfer | 1 | 2019 | 10 | 0.160 |
Why?
| | Radial Nerve | 1 | 2019 | 9 | 0.150 |
Why?
| | Orthopedics | 1 | 2021 | 144 | 0.150 |
Why?
| | Signal Transduction | 3 | 2007 | 5079 | 0.150 |
Why?
| | Tendon Transfer | 1 | 2019 | 23 | 0.150 |
Why?
| | Peripheral Nerve Injuries | 1 | 2019 | 36 | 0.150 |
Why?
| | Vascular Surgical Procedures | 2 | 2021 | 303 | 0.150 |
Why?
| | Metallurgy | 1 | 2018 | 8 | 0.150 |
Why?
| | Young Adult | 5 | 2024 | 13209 | 0.150 |
Why?
| | Tomography, X-Ray Computed | 1 | 2009 | 2691 | 0.150 |
Why?
| | Apoptosis | 2 | 2009 | 2553 | 0.140 |
Why?
| | Adult | 10 | 2025 | 37929 | 0.140 |
Why?
| | Ketones | 1 | 2018 | 49 | 0.140 |
Why?
| | Middle Aged | 9 | 2024 | 33479 | 0.140 |
Why?
| | Hand Injuries | 1 | 2017 | 31 | 0.140 |
Why?
| | Surgeons | 1 | 2021 | 297 | 0.140 |
Why?
| | Bone Screws | 1 | 2018 | 103 | 0.130 |
Why?
| | Metals | 1 | 2018 | 136 | 0.130 |
Why?
| | Neurosurgical Procedures | 1 | 2019 | 197 | 0.130 |
Why?
| | Chemokines, CXC | 2 | 2007 | 70 | 0.130 |
Why?
| | Sarcomeres | 5 | 2009 | 96 | 0.130 |
Why?
| | Administration, Topical | 2 | 2007 | 151 | 0.130 |
Why?
| | Fracture Healing | 2 | 2018 | 79 | 0.120 |
Why?
| | Female | 15 | 2025 | 73304 | 0.120 |
Why?
| | Resuscitation | 2 | 2008 | 251 | 0.120 |
Why?
| | Mycobacterium chelonae | 1 | 2015 | 9 | 0.120 |
Why?
| | Internship and Residency | 1 | 2025 | 1147 | 0.120 |
Why?
| | Burnout, Professional | 1 | 2021 | 442 | 0.110 |
Why?
| | Skin Diseases, Bacterial | 1 | 2015 | 21 | 0.110 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2007 | 323 | 0.110 |
Why?
| | Abscess | 1 | 2015 | 75 | 0.110 |
Why?
| | Accidents, Traffic | 2 | 2007 | 190 | 0.110 |
Why?
| | Lipopolysaccharides | 5 | 2009 | 886 | 0.110 |
Why?
| | Wrist Joint | 1 | 2014 | 62 | 0.100 |
Why?
| | Joint Diseases | 1 | 2014 | 60 | 0.100 |
Why?
| | Animals | 13 | 2009 | 36940 | 0.100 |
Why?
| | Polyethylene Glycols | 1 | 2018 | 641 | 0.100 |
Why?
| | Upper Extremity | 2 | 2023 | 99 | 0.100 |
Why?
| | Acute-Phase Proteins | 2 | 2009 | 67 | 0.100 |
Why?
| | Skin | 2 | 2007 | 752 | 0.090 |
Why?
| | Arthroscopy | 1 | 2014 | 222 | 0.090 |
Why?
| | Inflammation Mediators | 3 | 2009 | 513 | 0.080 |
Why?
| | Transplantation, Homologous | 1 | 2011 | 416 | 0.080 |
Why?
| | Myocytes, Cardiac | 4 | 2009 | 526 | 0.080 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2015 | 363 | 0.080 |
Why?
| | Membrane Glycoproteins | 2 | 2009 | 500 | 0.080 |
Why?
| | Dermis | 1 | 2009 | 33 | 0.080 |
Why?
| | Proprioception | 1 | 2009 | 26 | 0.080 |
Why?
| | Vagus Nerve Stimulation | 1 | 2009 | 29 | 0.080 |
Why?
| | Abdominal Wall | 1 | 2009 | 24 | 0.080 |
Why?
| | Reoperation | 1 | 2011 | 573 | 0.080 |
Why?
| | Microcirculation | 1 | 2009 | 149 | 0.070 |
Why?
| | Macrophage Migration-Inhibitory Factors | 1 | 2008 | 10 | 0.070 |
Why?
| | Smoke Inhalation Injury | 1 | 2008 | 28 | 0.070 |
Why?
| | Epidermis | 1 | 2009 | 157 | 0.070 |
Why?
| | Leukotriene B4 | 1 | 2008 | 42 | 0.070 |
Why?
| | Surgical Flaps | 1 | 2009 | 130 | 0.070 |
Why?
| | HMGB1 Protein | 1 | 2008 | 50 | 0.070 |
Why?
| | Carrier Proteins | 2 | 2009 | 771 | 0.070 |
Why?
| | Chemokine CXCL2 | 1 | 2007 | 43 | 0.070 |
Why?
| | Klebsiella Infections | 1 | 2007 | 26 | 0.070 |
Why?
| | Recovery of Function | 1 | 2011 | 653 | 0.070 |
Why?
| | Colony-Forming Units Assay | 1 | 2007 | 91 | 0.070 |
Why?
| | Fluid Therapy | 1 | 2008 | 147 | 0.070 |
Why?
| | Klebsiella pneumoniae | 1 | 2007 | 47 | 0.070 |
Why?
| | Shoulder Joint | 1 | 2009 | 173 | 0.070 |
Why?
| | Neutrophil Infiltration | 1 | 2007 | 107 | 0.070 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2007 | 382 | 0.070 |
Why?
| | Anabolic Agents | 1 | 2006 | 12 | 0.070 |
Why?
| | Oxandrolone | 1 | 2006 | 8 | 0.070 |
Why?
| | Wound Healing | 1 | 2009 | 331 | 0.060 |
Why?
| | Nutritional Support | 1 | 2006 | 34 | 0.060 |
Why?
| | Preoperative Care | 1 | 2009 | 362 | 0.060 |
Why?
| | Ventricular Function, Left | 1 | 2009 | 534 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2009 | 778 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2009 | 2057 | 0.060 |
Why?
| | Kupffer Cells | 1 | 2005 | 50 | 0.060 |
Why?
| | Pseudomonas Infections | 1 | 2007 | 225 | 0.060 |
Why?
| | Complement System Proteins | 1 | 2008 | 327 | 0.060 |
Why?
| | Aged | 4 | 2013 | 23961 | 0.060 |
Why?
| | Collagen | 1 | 2007 | 452 | 0.060 |
Why?
| | Complement Activation | 1 | 2008 | 415 | 0.060 |
Why?
| | Editorial Policies | 1 | 2025 | 52 | 0.060 |
Why?
| | Gene Expression | 2 | 2006 | 1502 | 0.060 |
Why?
| | Video Recording | 1 | 2025 | 180 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 976 | 0.060 |
Why?
| | Immunoglobulin G | 1 | 2009 | 893 | 0.060 |
Why?
| | Heart Failure | 2 | 2009 | 2236 | 0.060 |
Why?
| | Fracture Fixation, Internal | 2 | 2018 | 188 | 0.050 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 852 | 0.050 |
Why?
| | Hip Injuries | 1 | 2004 | 15 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2024 | 15657 | 0.050 |
Why?
| | Hip | 1 | 2004 | 56 | 0.050 |
Why?
| | Simulation Training | 1 | 2025 | 106 | 0.050 |
Why?
| | Protein Kinase Inhibitors | 1 | 2009 | 916 | 0.050 |
Why?
| | Phagocytosis | 1 | 2005 | 380 | 0.050 |
Why?
| | Mice | 4 | 2008 | 17787 | 0.050 |
Why?
| | Disease Models, Animal | 3 | 2008 | 4295 | 0.050 |
Why?
| | Cholestasis | 1 | 2005 | 235 | 0.050 |
Why?
| | Follow-Up Studies | 1 | 2011 | 5131 | 0.050 |
Why?
| | Nitric Oxide | 1 | 2007 | 915 | 0.050 |
Why?
| | Risk Assessment | 1 | 2011 | 3457 | 0.050 |
Why?
| | Clinical Protocols | 1 | 2023 | 271 | 0.050 |
Why?
| | Cardiomyopathies | 1 | 2005 | 350 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2008 | 5757 | 0.050 |
Why?
| | Immunotherapy | 1 | 2006 | 641 | 0.050 |
Why?
| | Cohort Studies | 1 | 2011 | 5742 | 0.040 |
Why?
| | Review Literature as Topic | 1 | 2021 | 75 | 0.040 |
Why?
| | Fibrinolytic Agents | 1 | 2023 | 270 | 0.040 |
Why?
| | Neutrophils | 1 | 2006 | 1238 | 0.040 |
Why?
| | Schools, Medical | 1 | 2021 | 147 | 0.040 |
Why?
| | Epithelial Cells | 1 | 2006 | 1096 | 0.040 |
Why?
| | Range of Motion, Articular | 2 | 2014 | 393 | 0.040 |
Why?
| | Wounds and Injuries | 1 | 2007 | 758 | 0.040 |
Why?
| | Job Satisfaction | 1 | 2021 | 218 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2011 | 10811 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 740 | 0.040 |
Why?
| | Anticoagulants | 1 | 2023 | 664 | 0.040 |
Why?
| | Benzophenones | 1 | 2018 | 16 | 0.040 |
Why?
| | Open Fracture Reduction | 1 | 2018 | 31 | 0.040 |
Why?
| | Biomarkers | 1 | 2009 | 4149 | 0.040 |
Why?
| | Lung | 2 | 2008 | 4060 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 5778 | 0.030 |
Why?
| | Materials Testing | 1 | 2018 | 356 | 0.030 |
Why?
| | Hospitals | 1 | 2021 | 691 | 0.030 |
Why?
| | Stress, Mechanical | 1 | 2018 | 485 | 0.030 |
Why?
| | Postoperative Complications | 2 | 2023 | 2654 | 0.030 |
Why?
| | Inflammation | 1 | 2006 | 2837 | 0.030 |
Why?
| | Ulna Fractures | 1 | 2014 | 13 | 0.030 |
Why?
| | Therapeutic Irrigation | 1 | 2015 | 77 | 0.030 |
Why?
| | Antibodies | 2 | 2007 | 410 | 0.030 |
Why?
| | Recombinant Proteins | 2 | 2009 | 1353 | 0.030 |
Why?
| | Joint Dislocations | 1 | 2014 | 50 | 0.030 |
Why?
| | Polymers | 1 | 2018 | 490 | 0.030 |
Why?
| | Contraindications | 1 | 2014 | 90 | 0.030 |
Why?
| | Drainage | 1 | 2015 | 173 | 0.030 |
Why?
| | Cells, Cultured | 3 | 2006 | 4193 | 0.030 |
Why?
| | Adolescent | 1 | 2011 | 21513 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2015 | 1236 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2009 | 3556 | 0.020 |
Why?
| | In Situ Nick-End Labeling | 1 | 2009 | 124 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 2069 | 0.020 |
Why?
| | Sex Factors | 2 | 2007 | 2071 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2008 | 106 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2009 | 325 | 0.020 |
Why?
| | Anthropometry | 1 | 2008 | 213 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2008 | 298 | 0.020 |
Why?
| | Air Bags | 1 | 2007 | 2 | 0.020 |
Why?
| | Seat Belts | 1 | 2007 | 20 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2009 | 372 | 0.020 |
Why?
| | Time Factors | 2 | 2008 | 6828 | 0.020 |
Why?
| | Pressure | 1 | 2007 | 225 | 0.020 |
Why?
| | Body Height | 1 | 2007 | 199 | 0.020 |
Why?
| | Regression Analysis | 1 | 2008 | 1024 | 0.020 |
Why?
| | Base Sequence | 1 | 2009 | 2181 | 0.020 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2005 | 60 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2008 | 652 | 0.010 |
Why?
| | Heart Rate | 1 | 2009 | 822 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2900 | 0.010 |
Why?
| | Safety | 1 | 2007 | 338 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 752 | 0.010 |
Why?
| | Craniocerebral Trauma | 1 | 2007 | 170 | 0.010 |
Why?
| | Blotting, Western | 1 | 2007 | 1226 | 0.010 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1809 | 0.010 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2007 | 250 | 0.010 |
Why?
| | United States | 1 | 2021 | 14841 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2007 | 1062 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2009 | 1242 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1092 | 0.010 |
Why?
| | Myocardium | 1 | 2009 | 1002 | 0.010 |
Why?
| | Finite Element Analysis | 1 | 2004 | 75 | 0.010 |
Why?
| | Survival Analysis | 1 | 2007 | 1325 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2007 | 1509 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2015 | 3566 | 0.010 |
Why?
| | Body Weight | 1 | 2007 | 985 | 0.010 |
Why?
| | Alcohol Drinking | 1 | 2008 | 828 | 0.010 |
Why?
| | Logistic Models | 1 | 2007 | 2074 | 0.010 |
Why?
| | Algorithms | 1 | 2008 | 1704 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2008 | 1587 | 0.010 |
Why?
| | Biomechanical Phenomena | 1 | 2004 | 810 | 0.010 |
Why?
| | Liver | 1 | 2009 | 1943 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2005 | 785 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2005 | 2833 | 0.010 |
Why?
| | Child | 1 | 2017 | 21935 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 3196 | 0.010 |
Why?
|
|
Ipaktchi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|